<?xml version="1.0" encoding="UTF-8"?>
<ref id="pvaa042-B6">
 <label>6</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Totura</surname>
    <given-names>AL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Whitmore</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Agnihothram</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sch√§fer</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Katze</surname>
    <given-names>MG</given-names>
   </name>, 
   <name name-style="western">
    <surname>Heise</surname>
    <given-names>MT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Baric</surname>
    <given-names>RS.</given-names>
   </name>
  </person-group>
  <article-title>Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection</article-title>. 
  <source>mBio</source>
  <year>2015</year>;
  <volume>6</volume>:
  <fpage>e00638</fpage>-
  <lpage>15</lpage>.
  <pub-id pub-id-type="pmid">26015500</pub-id>
 </mixed-citation>
</ref>
